Single-cell Omics Market Analysis

Single-cell Omics Market Analysis

To get key market trends

  Download Free Sample

By product type, the single-cell omics market is classified into single-cell genomics, single-cell proteomics, single-cell metabolomics, and single-cell transcriptomics. The single-cell genomics segment accounted for 42.8% of the business share in 2022 and is projected to witness considerable growth over the analysis timeframe. Single-cell genomics allows researchers to explore the genomic composition of individual cells, thereby help in revealing variations that remain hidden in aggregated analyses. Also, this technology provides insights into rare cell types, clonal populations, and subtle genetic mutations that hold crucial implications for various fields, from cancer research to developmental biology. Such associated advantages will supplement the market expansion.
 

Based on application, the single-cell omics market is segmented into oncology, cell biology, neurology, immunology, and other applications. The oncology segment accounted for 54.2% of the revenue share in 2022. The increasing prevalence of cancer, continuous advancements in single-cell analysis methods, and growing utilization of omics-based instruments for investigating cancer advancement are some of the major factors driving the market growth. Also, the continuous progress in metabolomics and the incorporation of single-cell metabolomics into cancer detection due to its heightened ability to detect cancer cells with increased sensitivity is expected to accelerate the market trends. Further, scientists are investigating diverse uses of single-cell technologies in various domains, encompassing genomics, transcriptomics, proteomics, and metabolomics.
 

Based on end-user, the single-cell omics market is segmented into academic and research organizations, pharmaceutical & biotechnology companies, hospital and diagnostic laboratories, and other end-users. The academic and research organizations segment is projected to witness considerable growth of 20% over the analysis timeframe. Increasing efforts from various market players to escalate their single-cell sequencing capabilities is anticipated to supplement the market growth. For instance, in February 2023, Singular Genomics Systems, Inc., launched its Max read kits for single cell applications on the company’s G4 sequencing platform. Such initiatives by market players will propel the market growth. Furthermore, increasing number of research studies conducted by various research institutes to explore a wide range of applications within the field of cellular biology will accelerate the market share.
 

North America single-cell omics market accounted for 47% business share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. North America has emerged as a hub for scientific innovation and technological advancement, fostering a dynamic environment conducive to the development and adoption of cutting-edge single-cell omics technologies. Moreover, the presence of several market players in the region will propel the market trends. Additionally, the region's strong emphasis on precision medicine and personalized healthcare aligns with the capabilities of single-cell omics, driving its integration into clinical research and diagnostics. Moreover, the availability of funding and strategic investments, coupled with regulatory support for innovation, further propels the growth of the market in North America.